(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.21%) $11.02
(0.56%) $0.808
(-0.95%) $93.01
@ $4.41
Issued: 14 Feb 2024 @ 15:08
Return: -20.63%
Previous signal: Feb 14 - 14:15
Previous signal:
Return: -0.23 %
Live Chart Being Loaded With Signals
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America...
Stats | |
---|---|
Today's Volume | 1.59M |
Average Volume | 2.31M |
Market Cap | 2.46B |
EPS | $0 ( 2024-03-14 ) |
Next earnings date | ( $-0.0600 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.54 |
ATR14 | $0.00600 (0.17%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-11 | Ronaghi Mostafa | Buy | 25 315 | Stock Option (right to buy) |
2024-04-11 | Ronaghi Mostafa | Buy | 200 000 | Stock Option (right to buy) |
2024-04-11 | Ronaghi Mostafa | Buy | 0 | |
2024-04-02 | Soni Manmeet Singh | Buy | 1 100 000 | Stock Option (right to buy) |
2024-04-02 | Anand Bhaskar | Buy | 600 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
99.44 |
Last 89 transactions |
Buy: 581 405 260 | Sell: 937 995 |
Volume Correlation
Summit Therapeutics plc Correlation
10 Most Positive Correlations | |
---|---|
BNIXU | 0.915 |
ACST | 0.898 |
DRTT | 0.89 |
GLMD | 0.881 |
CNXC | 0.872 |
ANGI | 0.869 |
BGNE | 0.868 |
YQ | 0.861 |
COLL | 0.86 |
ATIF | 0.86 |
10 Most Negative Correlations | |
---|---|
MTEK | -0.922 |
CINC | -0.873 |
SNCR | -0.868 |
LEDS | -0.858 |
PPBT | -0.858 |
SLDP | -0.858 |
PMD | -0.852 |
RIBT | -0.841 |
WKSP | -0.83 |
TSLA | -0.829 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Summit Therapeutics plc Correlation - Currency/Commodity
Summit Therapeutics plc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-2.05M (0.00 %) |
EPS: | $-0.990 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-605 000 (0.00 %) |
EPS: | $-0.0521 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-599 000 (0.00 %) |
EPS: | $-0.0305 |
Q2 | 2023 |
Revenue: | $235 000 |
Gross Profit: | $-236 000 (-100.43 %) |
EPS: | $-0.0211 |
Financial Reports:
No articles found.
Summit Therapeutics plc
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators